[AMRX] QoQ Quarter Result on 31-Mar-2023 [#Q1]

Stock
[AMRX] Amneal Pharmaceuticals, Inc.
Announcement Date
09-May-2023
Financial Year
2023
Quarter
31-Mar-2023 [#Q1]
Profit Trend
QoQ- -72.31%
YoY- -56.25%
Quarter Report
AMRX's Result
AMRX's Financial Summary
View:
Show?
Quarter Result
31/12/23 30/09/23 30/06/23 31/03/23 31/12/22 30/09/22 30/06/22 CAGR
Revenue 616,981 620,040 599,046 557,540 609,759 545,557 559,355 6.73%
PBT -83,461 22,957 29,660 -9,426 -7,655 2,180 -232,731 -49.42%
Tax 9,883 -2,076 -23 668 -1,797 4,570 7,350 21.75%
NP -98,649 9,682 11,917 -10,094 -5,858 -2,390 -120,808 -12.60%
Tax Rate - 9.04% 0.08% - - -209.63% - -
Total Cost 715,630 610,358 587,129 567,634 615,617 547,947 680,163 3.43%
Ratio Analysis
31/12/23 30/09/23 30/06/23 31/03/23 31/12/22 30/09/22 30/06/22 CAGR
NP Margin -15.99 1.56 1.99 -1.81 -0.96 -0.44 -21.60 -18.12%
Per Share
31/12/23 30/09/23 30/06/23 31/03/23 31/12/22 30/09/22 30/06/22 CAGR
EPS -0.40 0.06 0.08 -0.07 -0.04 -0.02 -0.80 -36.92%
EPS Diluted -0.40 0.06 0.08 -0.07 -0.04 -0.02 -0.80 -36.92%

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.